- 2018 Utilization Management Affirmative Statement
- Adoption Assistance or Permanency Care Assistance Managed Care Expansion
- Category II HEDIS Coding Tips
- Chimeric antigen receptor T-cell therapy requires prior authorization for all places of service
- CHIP Copay Changes
- CHIP Formulary Prior Auth Implementation – November
- CHIP Formulary Prior Auth Implementation – December
- Custom Shower Chairs Prior Authorization
- Dell Children’s Health Plan adopts Milliman Care Guidelines
- Eight Injectable Drugs Will Require Prior Authorization
- Electrical Stimulation Device to Require Prior Authorization
- Electronic Data Interchange Gateway Update
- Electronic Data Interchange (EDI) Update
- Elotuzumab to Require Prior Authorization
- Guidelines Update for Processing Therapy Precertification Requests
- January 2018 Medical Policies and CUMG Updates
- Lower extremity vascular intervention codes require prior authorization
- March 2018 Medical Policies and CUMG Updates
- Member Appeal Process Changes Notice to Providers
- Medical Policies and Clinical Utilization Management Guidelines – January 2018
- Medical Policies and Clinical Utilization Management Guidelines – March 2018
- Medical Policies and Clinical Utilization Management Guidelines update – May 2018
- Medical Policies and Clinical Utilization Management Guidelines Update – November 2018
- Miscellaneous Durable Medical Equipment Billing Guidelines
- Neonatal Level of Care Designation Required
- Non-Emergency Ambulance Prior Authorization Update
- Normal Newborn Diagnosis-Related Group Claims Processing Update
- Notification of Joint Venture
- Overpayment Identification and Refund Requirements
- P4Q Provider Incentive Plan
- Post-Payment Reviews of Distinct Procedural Service Modifiers
- Prenatal and Postpartum Outreach Initiatives
- Prior Authorization Requirement Update for Mylotarg
- Prior Authorization Requirements for Cabazitaxel
- Prior Authorization Requirements for Darzalex Drug
- Prior Authorization Requirements for Injectable/Infusible Drugs: Mepolizumab (Nucala) and Reslizumab (Cinqair)
- Services Requiring Prior Authorization
- Spinraza Clinician-Administered Drug Prior Authorization Requirements
- Update Regarding Appointment Availability Standards
- Update to Ordering/Prescribing/Referring Claim Submissions
- What Matters Most: Improving the Patient Experience CME
June 6, 2019